Description
TK Substrate
| Catalog number: | B2014291 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 L |
| Molecular Weight or Concentration: | N/A |
| Supplied as: | Solution |
| Applications: | molecular tool for various biochemical applications |
| Storage: | 20C |
| Keywords: | TK Substrate |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Zhang H. HSV1-TK/GFP/Fluc 2008 Oct 21 [updated 2008 Dec 1]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 20042013.
- Shan L. 1-(2-Deoxy-2-[(18)F]fluoro-_-d-arabinofuranosyl)-5-iodocytosine 2012 Mar 19 [updated 2012 Apr 11]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 20042013.
- The MICAD Research Team. (99m)Tc-Ethylenedicysteine-guanine 2007 Aug 17 [updated 2007 Sep 19]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 20042013.
- Solaroli N, Johansson M, Balzarini J, Karlsson A. Substrate specificity of three viral thymidine kinases (TK): vaccinia virus TK, feline herpesvirus TK, and canine herpesvirus TK Nucleosides Nucleotides Nucleic Acids. 2006;25(9-11):1189-92.
- Leung K. 2-Fluoro-2-deoxy-5-[(123/124/125/131)I]iodo-1_-d-arabinofuranosyluracil 2005 Feb 1 [updated 2005 Feb 9]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 20042013.
- Wilkinson HC, Dalby PA. The Two-Species Model of transketolase explains donor substrate-binding, inhibition and heat-activation Sci Rep. 2020 Mar 5;10(1):4148.
- Solaroli N, Johansson M, Persoons L, Balzarini J, Karlsson A. Substrate specificity of feline and canine herpesvirus thymidine kinase Antiviral Res. 2008 Aug;79(2):128-32.
- De Clercq E. (E)-5-(2-bromovinyl)-2-deoxyuridine (BVDU) Med Res Rev. 2005 Jan;25(1):1-20.
- De Clercq E. The development of BVDU: An odyssey Antivir Chem Chemother. 2023 Jan-Dec;31:20402066231152971.
